Mark A. DePristo

From GSA

Mark DePristo, PhD, leads the Genome Sequencing and Analysis Group in the Medical and Population Genetics Program at the Broad Institute in Cambridge, MA. Dr. DePristo's team of computational biologists and software engineers lead the development of methods to apply next-generation DNA sequencing technologies in medical genetics. In additional, Dr. DePristo also leads the analysis team for the 1000 Genomes project at the Broad that is applying these tools to characterize all common human genetic variation. He and members of his team have presented their work at professional conferences throughout the world, are contributing fundamental analyses to international research projects and their publications, and are helping build a production quality pipeline for the analysis of next-generation DNA sequencing data at the Broad.

From 2004 to 2007, he held a Damon Runyon Cancer Research Foundation fellowship in Dan Hartl's group's group in the Department of Organismic and Evolutionary Biology at Harvard University, as well as a visiting scholarship in Jim Collin's Biodynamics Lab at Boston University. Dr. DePristo’s postdoctoral research focused on characterizing the selective pressures and constraints on protein evolution due to structure, folding, and interaction with other molecules. He completed his Ph.D. in the Crystallography and Biocomputing Group run by Professor Sir Tom Blundell in the Department of Biochemistry at the University of Cambridge, supported by a U.S. National Science Foundation Graduate Research Fellowship (2002) and a British Marshall Scholarship (2000).

You can view my list of publications or just my File:Depristo cv.pdf.